Metformin
met-FOR-meen
Category
Compound type
Phase / Status
FDA approved. Generic dirt cheap. TAME trial testing anti-aging effects. One of the most studied drugs on earth.
Standard Dose
1-2x daily with meals
Half-life
Plasma elimination
Route(s)
Oral
Research Stage
Regulatory approval granted; post-market monitoring ongoing.
Overview
Metformin helps lower blood glucose and improve insulin sensitivity. Many people start on a lower dose and take it with food to improve stomach tolerance, and side effects like nausea or diarrhea often improve over time. Any ‘longevity’ use should be discussed with a clinician since the evidence for aging-related effects is not yet definitive.
Plain-language summary
Metformin helps lower blood glucose and improve insulin sensitivity. Many people start on a lower dose and take it with food to improve stomach tolerance, and side effects like nausea or diarrhea often improve over time. Any ‘longevity’ use should be discussed with a clinician since the evidence for aging-related effects is not yet definitive.
Administration Routes
- Oral
Also known as
Mechanisms
Biguanide - activates AMPK (the cellular energy sensor), inhibits mitochondrial complex I, reduces liver glucose production. Basically forces cells to burn fuel more efficiently.
Detailed mechanism
Biguanide - activates AMPK, inhibits mitochondrial complex I, reduces hepatic glucose production. Modulates cellular energy metabolism to improve insulin sensitivity and glucose utilization.
Safety
Side effects
- GI distress (diarrhea, nausea) - usually temporary
- Metallic taste in mouth
- Vitamin B12 deficiency with long-term use
- Lactic acidosis (rare but serious)
- Take with food to reduce gut issues
Reported benefits
- Lowers blood sugar effectively
- May improve insulin sensitivity
- Potential anti-aging effects being studied
- Helps with modest weight management
- Cardiovascular benefits
- Decades of safety data
Safety profile
Well-characterized safety profile from 60+ years of clinical use. Monitor kidney function and B12 levels.
Clinical trials
Completed clinical trials leading to FDA approval. TAME trial ongoing for anti-aging indication.
Structure
Verified structure
Metformin
Exact 2D structure can be rendered from a PubChem-backed canonical SMILES string.
- Chemical Formula
- C4H11N5
- Molecular Weight
- 165.63 g/mol
- CAS Number
- 1115-70-4
- InChIKey
- XZWYZXLIPXDOLR-UHFFFAOYSA-N
Stack Context
Stacks with
Comparison context
Unlike berberine, which also activates AMPK but barely gets absorbed, metformin actually reaches systemic circulation at therapeutic doses. Compared to semaglutide, metformin doesn't cause significant weight loss, it's a gentle metabolic stabilizer, not an appetite killer. Rapamycin also targets longevity but through mTOR inhibition rather than AMPK; metformin is far safer for long-term use.
References
- 1View source
Metformin and longevity: a review of mechanisms and evidence (Cell Metabolism)
2016
- 2View source
Effect of metformin on all-cause mortality (Lancet)
1998
This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.
